{"id":912943,"date":"2026-11-10T23:58:18","date_gmt":"2026-11-10T23:58:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/912943\/"},"modified":"2026-11-10T23:58:18","modified_gmt":"2026-11-10T23:58:18","slug":"former-lilly-rep-claims-she-was-fired-for-complaining-about-mounjaro-marketing","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/912943\/","title":{"rendered":"Former Lilly rep claims she was fired for complaining about Mounjaro marketing"},"content":{"rendered":"<p class=\"author-bio\">Ed\u2019s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning <a href=\"https:\/\/www.statnews.com\/signup\/pharmalittle\/\" rel=\"nofollow noopener\" target=\"_blank\">Pharmalittle newsletter<\/a> and the afternoon <a href=\"https:\/\/www.statnews.com\/signup\/pharmalot\/\" rel=\"nofollow noopener\" target=\"_blank\">Pharmalot newsletter<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining the company was promoting its Mounjaro diabetes drug to combat weight loss before receiving regulatory approval to do so.<\/p>\n<p class=\"wp-block-paragraph\">Jennifer Mansion, who was hired as a senior territory manager in Dallas four years ago, claimed that she observed other Lilly sales reps promoting the diabetes drug as a salve for obesity. Mansion also contended that a physician touted Mounjaro as a weight loss option during a luncheon sponsored by the drugmaker, according to <a href=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/11\/lilly-vs-mansion-sales-rep-moujaro.pdf\" id=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/11\/lilly-vs-mansion-sales-rep-moujaro.pdf\" rel=\"nofollow noopener\" target=\"_blank\">the suit<\/a> filed in federal court in Texas.<\/p>\n<p class=\"wp-block-paragraph\">Such promotions are known as off-label marketing in the pharmaceutical industry. The phrase refers to promoting a medicine for a usage that was not approved by the Food and Drug Administration. A physician may prescribe a medicine for an unapproved use, but a drugmaker is not permitted to market its drug for that purpose.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/11\/1794355098_695_stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Ed\u2019s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He&hellip;\n","protected":false},"author":2,"featured_media":912944,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[48123,97,1341,243,986,247,248,3458],"class_list":["post-912943","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-eli-lilly","tag-health","tag-medicaid","tag-medication","tag-obesity","tag-pharmaceuticals","tag-stat","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/912943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=912943"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/912943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/912944"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=912943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=912943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=912943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}